Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit



Status:Terminated
Healthy:No
Age Range:Any - 2
Updated:2/1/2019
Start Date:May 7, 2015
End Date:November 30, 2016

Use our guide to learn which trials are right for you!

Development of MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit

This study investigates a novel magnetic resonance imaging (MRI) system designed by GEHC for
imaging viable neonate and infant populations. This MR system has a smaller size and design
features that may make it more feasible to locate the system in close proximity to care areas
for neonates (birth - 1 month) and infants (less than 1 month to two years), such as clinical
neonatal intensive care units (NICUs) and other infant and neonatal care departments.

This study investigates a novel magnetic resonance imaging (MRI) system designed by GEHC for
imaging viable neonate and infant populations. This MR system has a smaller size and design
features that may make it more feasible to locate the system in close proximity to care areas
for neonates (birth - 1 month) and infants (>1 month to two years), such as clinical neonatal
intensive care units (NICUs) and other infant and neonatal care departments.

This is a two-phase prospective clinical study evaluating the performance and safety of the
investigational MRI device for neonates and infants, including:

- Phase 1 - Initial feasibility assessment and optimization study (Phase 1) which may
include hardware and software modifications. These studies are guided by a series of MR
scanning procedures defined in sequential Sponsor-provided MR Procedure Documents

- Phase 2 - Controlled image and data collection study based on Phase 1 results, in which
optimized scan procedure(s) according to MR Procedure Document(s) will be provided at
the start of Phase 2 scanning and a fixed hardware and integrated software configuration
will be applied for all subjects.

Inclusion Criteria:

Subjects will be included that are:

1. Currently admitted for treatment or observation at the investigational site at the
time of enrollment;

2. In the weight range less than 5.0 kg (<5.0 kg ) and more than 0.5 kg (>0.5 kg );

3. Viable neonates (birth to 1 month of age) or infants (>1 month to two years of age);

4. Able to safely undergo an MRI scan, as determined by the site's co-investigator
neonatologist or medically qualified delegate;

5. Have parent(s), guardian(s), or legally authorized representative(s) willing and able
to provide written informed consent for the subject's participation;

6. Are of appropriate size and shape to fit into the bore of the magnet, inclusive of all
monitoring equipment, if any, necessary for the subject's routine clinical care:

1. Maximum width (shoulder-to-shoulder measurement) less than eighteen (18 cm).

2. Maximum length (head-to-foot measurement) less than sixty (60) cm. -

Exclusion Criteria:

- Subjects will be excluded that:

1. Have parent(s), guardian(s), or legally authorized representative(s) that require
that they accompany the subject into the MR environment that have
contraindications to the MR environment or would otherwise be put at undue risk
or discomfort, as determined by the investigators;

2. Require any non-removable medical devices that are not compatible with MR
scanning (labeled as MR Unsafe, MR condition for which the scanning conditions
are not met, or no MR safety labeling) that may pose hazards in the MR scanning
or MR environment, in the opinion of the neonatologist co-investigator or
medically qualified delegate;

3. Have other contraindications or could otherwise be expected to experience
detrimental effects to safety, well-being, or medical care, as determined by the
neonatologist co-investigator;

4. Require any scheduled standard of care procedures that are expected to be
adversely impacted by participation in this study, in the opinion of the
principal investigator, neonatologist co-investigator, or medically qualified
delegate; and

5. Have been previously enrolled AND undergone any study procedures under the
current study protocol (i.e. the same subject cannot undergo study procedures,
including swaddling and/or MR scanning, more than once).
We found this trial at
1
site
300 Longwood Ave
Boston, Massachusetts 02115
(617) 355-6000
Principal Investigator: Ellen Grant, MD
Phone: 857-218-5111
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
?
mi
from
Boston, MA
Click here to add this to my saved trials